Detalhe da pesquisa
1.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081848
2.
Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer.
Anticancer Drugs
; 30(8): 866-872, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31305270
3.
Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study.
Cancer Chemother Pharmacol
; 83(6): 1147-1158, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30976844